Scilex Holding (SCLX) Interest Coverage Ratio (2021 - 2026)
Scilex Holding (SCLX) posted quarterly Interest Coverage Ratio of 8.51 for Q1 2026, up 24.3% year-over-year from 6.85 in Q1 2025, and up 73.2% on a QoQ basis from 31.76 in Q4 2025.
Scilex Holding (SCLX) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Scilex Holding (SCLX) has reported Interest Coverage Ratio for 6 consecutive years, with 8.51 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 24.3% year-over-year to 8.51; the TTM figure through Mar 2026 stood at 27.46 (down 17.02% YoY), while the FY2025 annual figure was 30.2, up 28.93% from the prior year.
- Interest Coverage Ratio came in at 8.51 for Q1 2026 at Scilex Holding, up from 31.76 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 4.83 in Q1 2023, with the low at 1385.39 in Q2 2022.
- Average Interest Coverage Ratio over 5 years is 178.46, with a median of 31.76 recorded in 2025.
- The largest YoY upside for Interest Coverage Ratio was 99.59% in 2023 against a maximum downside of 1223.9% in 2023.
- Year by year, Interest Coverage Ratio stood at 19.58 in 2022, then slumped by 69.95% to 33.28 in 2023, then slumped by 199.17% to 99.57 in 2024, then soared by 68.11% to 31.76 in 2025, then surged by 73.2% to 8.51 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 8.51, 31.76, and 66.66 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 23.39 |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -10.80 |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 4.06 |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 10.78 |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Scilex Holding | 54.30 Mn | -95.62 Mn | 4.15 Mn | -8.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.51 |
| Dec 31, 2025 | -31.76 |
| Sep 30, 2025 | -66.66 |
| Jun 30, 2025 | -7.65 |
| Mar 31, 2025 | -11.24 |
| Dec 31, 2024 | -99.57 |
| Sep 30, 2024 | -34.58 |
| Jun 30, 2024 | -27.36 |
| Mar 31, 2024 | -36.68 |
| Dec 31, 2023 | -33.28 |
| Sep 30, 2023 | -75.64 |
| Jun 30, 2023 | -5.94 |
| Mar 31, 2023 | -4.83 |
| Dec 31, 2022 | -19.58 |
| Sep 30, 2022 | -5.71 |
| Jun 30, 2022 | -1,385.39 |
| Mar 31, 2022 | -1,179.48 |
| Dec 31, 2021 | -704.35 |